# Biomarkers for Hunter Syndrome

> **NCT01330277** · — · TERMINATED · sponsor: **CENTOGENE GmbH Rostock** · enrollment: 11 (actual)

## Conditions studied

- Hunter Syndrome
- Mucopolysaccharidosis II
- Hunter's Syndrome, Mild Form
- Hunter's Canal Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01330277
- **Lead sponsor:** CENTOGENE GmbH Rostock
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-20
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study no longer pursued.
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01330277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01330277, "Biomarkers for Hunter Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01330277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*